Sensydia Appoints Anthony Arnold as President and Chief Executive Officer

LOS ANGELES--(BUSINESS WIRE)--Sensydia Corporation, an innovator in rapid, non-invasive measurement of critical cardiac function, announced that industry leader Anthony Arnold has been appointed as chief executive officer and president and joins the Board of Directors. Arnold is a pioneer in bioelectronic medicine and surgical navigation and brings more than 20 years of leadership experience from a range of medical technology companies including Smith+Nephew, Medtronic, Boston Scientific and SetPoint Medical.

“Anthony’s appointment comes at an exciting time for Sensydia, as the company builds on its lead product, the FDA-approved Cardiac Performance System (CPS™), to strengthen and expand its technical capabilities and clinical applications,” said Aman Mahajan, MD, PhD, founder and chief medical officer of Sensydia. “Anthony’s expertise and leadership in the medtech field will help position Sensydia and advance its innovative technology to commercialization.”

Click here for more…..